Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EU-COVAT-1: COVID-19 Vaccine Boosters in Older Adults
NCT05160766Phase 2Completed
- Start
- Nov 2021
- Primary completion
- Oct 2022
- Modality
- Vaccines & Immunotherapeutics, Lipid-based Nanoparticles, mRNA Therapeutics
- Countries
- 4
01
Overview
A Phase 2 trial of tozinameran, elasomeran in coronavirus disease 2019 (COVID-19). Started Nov 2021; status: completed.
02
Drugs
tozinameranelasomeran
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05160766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05160766.